Lenvatinib Mesylate
857890-39-2

Lenvatinib Mesylate; CAS 857890-39-2 is a medication for the treatment of certain kinds of thyroid cancer

Fountainbridge can supply the following Active Pharmaceutical Ingredients (API), please Contact Us for a quotation for these or any other products of interest.